Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats

Takakura Shoji; Toyoshi Tohru; Hayashizaki Yuka; Takasu Toshiyuki

首页> 外文期刊>Life sciences >Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats

【24h】

Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats

机译：SGLT2抑制剂ipragliflozin对自发性Torii肥胖大鼠糖尿病微血管并发症进展的影响

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aims: We investigated the effect of the selective sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin on the simultaneous progression of diabetic microvascular complications of retinopathy, nephropathy and neuropathy in individual Spontaneously Diabetic Torii (SDT) fatty rats.

机译：目的：我们研究了选择性钠依赖性葡萄糖共转运蛋白2抑制剂依普格列净对自发性糖尿病鸟（SDT）脂肪大鼠视网膜病变，肾病和神经病变的糖尿病微血管并发症同时进展的影响。

著录项

来源
《Life sciences》 |2016年第null期|共7页
作者
Takakura Shoji; Toyoshi Tohru; Hayashizaki Yuka; Takasu Toshiyuki;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Type 2 diabetes mellitus; Diabetic microvascular complications; Retinopathy; Nephropathy; Neuropathy; Cataract; Sodium-dependent glucose cotransporter 2; Ipragliflozin L-proline (PubChem CID: 57339444);

机译：2型糖尿病;糖尿病微血管并发症;视网膜病变;肾病;神经病;白内障;钠依赖性葡萄糖共转运蛋白2;伊格列净L-脯氨酸（PubChem CID：57339444）;

相似文献

外文文献
中文文献
专利

1. Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats [J] . Takakura Shoji, Toyoshi Tohru, Hayashizaki Yuka, Life sciences . 2016,第Null期

机译：SGrt2抑制剂Ipragliflozin的作用，在自发性糖尿病菌脂肪大鼠中糖尿病微血管并发症的进展
2. Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats [J] . Takakura Shoji, Toyoshi Tohru, Hayashizaki Yuka, Life sciences . 2016,第Null期

机译：SGLT2抑制剂ipragliflozin对自发性Torii肥胖大鼠糖尿病微血管并发症进展的影响
3. First-dose effect of the SGLT2 inhibitor ipragliflozin on cardiovascular activity in spontaneously diabetic Torii fatty rats [J] . Shoji Takakura, Toshiyuki Takasu Clinical and experimental pharmacology & physiology . 2019,第3期

机译：SGLT2抑制剂Ipragliflozin对自发性糖尿病菌脂肪大鼠心血管活性的第一剂效应
4. Long-Term Quality-Of-Care Summary Score Predicts the Occurrence of Microvascular and Macrovascular Complications in Type 2 Diabetic Patients [C] . Pi-l Li, How-Ran Guo Joint annual meeting of the International Society of Exposure Science and the International Society for Environmental Epidemiology . 2018

机译：长期护理质量摘要分数可预测2型糖尿病患者微血管和大血管并发症的发生率
5. The use of intestinal microflora modification to maximize the anti-obesity and anti-diabetic effects of soy protein diets in female Zucker diabetic fatty rats. [D] . Martin, Michele Marie. 2008

机译：肠道菌群修饰的使用可最大程度地提高雌性Zucker糖尿病脂肪大鼠的大豆蛋白饮食的抗肥胖和抗糖尿病作用。
6. Metabolic Disorders and Diabetic Complications in Spontaneously Diabetic Torii Leprfa Rat: A New Obese Type 2 Diabetic Model [O] . Yusuke Kemmochi, Kenji Fukui, Mimi Maki, 2013

机译：自发性糖尿病患者的代谢紊乱和糖尿病并发症fa大鼠：一种新型的肥胖2型糖尿病模型
7. Ocular changes –cataract and retinal lesion- in Spontaneously Diabetic Torii (SDT) fatty rats, an obese type 2 diabetic model [O] . Tatsuya Maekawa, Sanae Nakamura, Katsuhiro Miyajima, 2021

机译：眼部变化 - 疾病和视网膜病变 - 在自发性糖尿病菌革（SDT）脂肪大鼠中，肥胖2型糖尿病模型

Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats

摘要

著录项

相似文献

相关主题

期刊订阅